Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The menopause and vascular risk].

H Rozenbaum

    Revue Francaise De Gynecologie Et D'Obstetrique
    |March 1, 1985
    PubMed
    Summary

    The vascular risk of oestrogen therapy is debated. However, no vascular events have been reported in menopausal women using natural oestrogens, suggesting risk can be minimized with proper monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of a standard design medication room to promote medication safety: organizational implications.

    International journal for quality in health care : journal of the International Society for Quality in Health Care·2013
    Same author

    Use of colour-coded labels for intravenous high-risk medications and lines to improve patient safety.

    Quality & safety in health care·2009
    Same author

    [Hormone replacement therapy in menopause: continue or stop the prescription after 10 years? There are reasons to continue hormone replacement therapy longer than 10 years].

    Gynecologie, obstetrique & fertilite·2002
    Same author

    Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.

    Climacteric : the journal of the International Menopause Society·2002
    Same author

    [Hormone replacement therapy and increased risk of breast cancer. Opinion of the French Association for the Study of Menopause].

    Annales d'endocrinologie·2000
    Same author

    [Why has menopause become a public health problem?].

    Anales de la Real Academia Nacional de Medicina·2000

    Area of Science:

    • Endocrinology
    • Cardiovascular Medicine
    • Women's Health

    Context:

    • The administration of oestrogen therapy for menopausal symptoms carries a debated vascular risk.
    • Assessing this risk is challenging due to limited conclusive data.
    • Existing literature lacks published reports of vascular accidents in menopausal women treated with natural oestrogens.

    Purpose:

    • To evaluate the association between oestrogen administration and vascular risk in menopausal women.
    • To explore the current understanding and evidence regarding oestrogen-related vascular complications.
    • To determine if natural oestrogens pose a significant vascular risk.

    Summary:

    • The vascular risk associated with oestrogen therapy is a complex and contentious issue.
    • Despite widespread acknowledgment of potential risks by many, definitive evidence remains elusive.
    • Crucially, no vascular accidents have been documented in menopausal women treated with natural oestrogens to date.
    • Population analysis suggests that careful identification of risk factors and consistent patient surveillance can substantially mitigate the likelihood of vascular events.

    Impact:

    • Highlights the need for individualized risk assessment in hormone replacement therapy.
    • Suggests natural oestrogens may offer a safer alternative for managing menopausal symptoms.
    • Emphasizes the importance of proactive patient monitoring to minimize potential adverse events.
    • Informs clinical practice regarding the cautious use of oestrogen therapy in postmenopausal women.

    Related Experiment Videos